mitomycin has been researched along with ginsenosides in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kubo, M; Matsuda, H; Tong, CN | 1 |
| Chen, ZJ; Cheng, J; Han, SL; Huang, YP; Liu, NX; Yao, JG; Zhu, GB | 1 |
| Cao, LJ; Che, Y; Hao, HP; Li, QR; Shao, C; Wang, DD; Wang, GJ; Wang, Y; Wu, MQ; Zhao, M | 1 |
| Gu, S; Jin, L; Ma, J; Ni, X; Pan, Q; Wang, J; Xu, M; Zhen, N; Zhu, J | 1 |
1 trial(s) available for mitomycin and ginsenosides
| Article | Year |
|---|---|
[Effect of adjuvant chemotherapy of ginsenoside Rg3 combined with mitomycin C and tegafur in advanced gastric cancer].
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Chemotherapy, Adjuvant; Female; Ginsenosides; Humans; Male; Middle Aged; Mitomycin; Neoplasm Staging; Phytotherapy; Stomach Neoplasms; Survival Rate; Tegafur; Vascular Endothelial Growth Factor A | 2007 |
3 other study(ies) available for mitomycin and ginsenosides
| Article | Year |
|---|---|
[Pharmacological study on Panax ginseng C. A. Meyer. XV. Effects of 70% methanolic extract from red and white ginseng on the antitumor activity of mitomycin C].
Topics: Animals; Carcinoma, Ehrlich Tumor; Drug Screening Assays, Antitumor; Drug Synergism; Drugs, Chinese Herbal; Ginsenosides; Liver Neoplasms, Experimental; Methanol; Mice; Mitomycin; Panax; Plants, Medicinal; Rats; Saponins; Tumor Cells, Cultured | 1992 |
Ginsenosides synergize with mitomycin C in combating human non-small cell lung cancer by repressing Rad51-mediated DNA repair.
Topics: Animals; Cell Cycle Checkpoints; Cell Line, Tumor; DNA Repair; Down-Regulation; Drug Synergism; Ginsenosides; Humans; MAP Kinase Signaling System; Mice; Mitomycin; Phosphorylation; Rad51 Recombinase; Xenograft Model Antitumor Assays | 2018 |
Ginsenoside Rg1 impairs homologous recombination repair by targeting CtBP-interacting protein and sensitizes hepatoblastoma cells to DNA damage.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Carrier Proteins; Cell Growth Processes; Cell Line, Tumor; DNA Damage; Drug Synergism; Endodeoxyribonucleases; Ginsenosides; Hep G2 Cells; Hepatoblastoma; Humans; Hydroxyurea; Liver Neoplasms; Male; Mice; Mice, Nude; Mitomycin; Nuclear Proteins; Phthalazines; Piperazines; Random Allocation; Recombinational DNA Repair; Xenograft Model Antitumor Assays | 2018 |